Exploring the Potential of Chatbots in Critical Care Nephrology
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
The exponential growth of artificial intelligence (AI) has allowed for its integration into multiple sectors, including, notably, healthcare. Chatbots have emerged as a pivotal resource for improving patient outcomes and assisting healthcare practitioners through various AI-based technologies. In critical care, kidney-related conditions play a significant role in determining patient outcomes. This article examines the potential for integrating chatbots into the workflows of critical care nephrology to optimize patient care. We detail their specific applications in critical care nephrology, such as managing acute kidney injury, alert systems, and continuous renal replacement therapy (CRRT); facilitating discussions around palliative care; and bolstering collaboration within a multidisciplinary team. Chatbots have the potential to augment real-time data availability, evaluate renal health, identify potential risk factors, build predictive models, and monitor patient progress. Moreover, they provide a platform for enhancing communication and education for both patients and healthcare providers, paving the way for enriched knowledge and honed professional skills. However, it is vital to recognize the inherent challenges and limitations when using chatbots in this domain. Here, we provide an in-depth exploration of the concerns tied to chatbots’ accuracy, dependability, data protection and security, transparency, potential algorithmic biases, and ethical implications in critical care nephrology. While human discernment and intervention are indispensable, especially in complex medical scenarios or intricate situations, the sustained advancements in AI signal that the integration of precision-engineered chatbot algorithms within critical care nephrology has considerable potential to elevate patient care and pivotal outcome metrics in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ELIZA—a computer program for the study of natural language communication between man and machine
Weizenbaum, J. (1966) · Communications of the ACM · doi:10.1145/365153.365168 · Cited by 4,452 · cited 1×
“Notably, a precursor to modern chatbots, known as ELIZA, emerged in the 1960s as a program designed to simulate conversation with a Rogerian psychotherapist [4–6].”
BackgroundThe potential for artificial intelligence in healthcare
Davenport, T., & Kalakota, R. (2019) · Future Healthcare Journal · doi:10.7861/futurehosp.6-2-94 · Cited by 3,800
Rajpurkar, P., Chen, E., Banerjee, O., & Topol, E. J. (2022) · Nature Medicine · doi:10.1038/s41591-021-01614-0 · Cited by 3,212 · cited 3×
“Healthcare organizations commonly employ a variety of systems, including EHRs, laboratory information systems, and appointment scheduling platforms [8,25].”
BackgroundSallam, M. (2023) · Healthcare · doi:10.3390/healthcare11060887 · Cited by 3,126 · cited 2×
“Healthcare professionals in critical care nephrology can leverage chatbots to access up-to-date medical literature, guidelines, and protocols [83].”
BackgroundMachine learning and deep learning
Janiesch, C., Zschech, P., & Heinrich, K. (2021) · Electronic Markets · doi:10.1007/s12525-021-00475-2 · Cited by 2,959 · cited 1×
“(2) Machine learning plays a pivotal role in the development of chatbots, enabling them to learn from data and improve their performance [2,3,14].”
BackgroundAyers, J. W., Poliak, A., Dredze, M., Leas, E. C., Zhu, Z., Kelley, J. B., Faix, D. J., Goodman, A. M., Longhurst, C. A., Hogarth, M., et al. (2023) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2023.1838 · Cited by 2,613
Natural language processing: state of the art, current trends and challenges
Khurana, D., Koli, A., Khatter, K., & Singh, S. (2023) · Multimedia Tools and Applications · doi:10.1007/s11042-022-13428-4 · Cited by 1,823 · cited 2×
“The critical components of chatbots are as follows: (1) Natural language processing (NLP) forms the foundation of chatbot technology, a subfield of AI that empowers machines to comprehend and process human language [9–11].”
BackgroundLearning under Concept Drift: A Review
Lu, J., Liu, A., Dong, F., Gu, F., Gama, J., & Zhang, G. (2018) · IEEE Transactions on Knowledge and Data Engineering · doi:10.1109/tkde.2018.2876857 · Cited by 1,603
Artificial hallucinations in ChatGPT: implications in scientific writing
Alkaissi, H., & McFarlane, S. I. (2023) · Cureus · doi:10.7759/cureus.35179 · Cited by 1,540
Artificial Intelligence and Machine Learning in Clinical Medicine, 2023
Haug, C. J., & Drazen, J. M. (2023) · New England Journal of Medicine · doi:10.1056/nejmra2302038 · Cited by 1,215
Cited by
Bui, N. M., & Barrot, J. S. (2025) · Education and Information Technologies · doi:10.1007/s10639-024-12891-w · Cited by 113
“This phenomenon is known as model drift (Gonzalez Torres & Sawhney, 2023; Suppadungsuk et al., 2023).”
Miao, J., Thongprayoon, C., Suppadungsuk, S., Garcia Valencia, O. A., Qureshi, F., & Cheungpasitporn, W. (2023) · Clinics and Practice · doi:10.3390/clinpract14010008 · Cited by 111
“Specifically, in our nephrology-focused research, we have explored chatbot applications in critical care nephrology [23], kidney transplant care [24], renal diet support [25], nephrology literature searches [26], and answering nephrology-related questions [27].”
BackgroundSelf-citationChow, J. C. L., & Li, K. (2024) · JMIR Bioinformatics and Biotechnology · doi:10.2196/64406 · Cited by 75
Chatbots in cancer applications, advantages and disadvantages: all that glitters is not gold
Goumas, G., Dardavesis, T. I., Syrigos, K., Syrigos, N., & Simou, E. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14080877 · Cited by 24
Metadata
- Authors
- Suppadungsuk, S., Thongprayoon, C., Miao, J., Krisanapan, P., Qureshi, F., Kashani, K., & Cheungpasitporn, W.
- Venue
- Medicines
- Publisher
- MDPI AG
- Published
- 2023-10-20
- Volume
- 10
- Issue
- 10
- Pages
- 58
- ISSN
- 2305-6320 (ISSN-L)
- OpenAlex
- W4387843512
- Cited by
- 37
- References
- 36
- FWCI
- 1.28
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Exploring the Potential of Chatbots in Critical Care Nephrology. https://app.cochat.ai/papers/10.3390/medicines10100058
- The paper
- Suppadungsuk, S., Thongprayoon, C., Miao, J., Krisanapan, P., Qureshi, F., Kashani, K., & Cheungpasitporn, W. (2023). Exploring the Potential of Chatbots in Critical Care Nephrology. Medicines. https://doi.org/10.3390/medicines10100058
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.